LT - A COMBINATION COMPRISING USING AN OLIGOPEPTIDIC COMPOUND AND ANTI-PD-1 OR PD-L1 ANTIBODY FOR USE IN TREATING NEOPLASTIC CONDITIONS
EN - A COMBINATION COMPRISING USING AN OLIGOPEPTIDIC COMPOUND AND ANTI-PD-1 OR PD-L1 ANTIBODY FOR USE IN TREATING NEOPLASTIC CONDITIONS
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61P 35/00 |
(2006.01) |
|
|
A61K 38/16 |
(2013.01) |
|
|
A61K 38/16 |
(2006.01) |
|
|
A61K 39/3955 |
(2013.01) |
|
|
A61K 39/395 |
(2006.01) |
|
|
A61K2039/505 |
(2013.01) |
|
|
A61K2039/545 |
(2013.01) |
|
|
C07K 16/2818 |
(2013.01) |
European patent
| (11) |
Number of the document |
3810279 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
19734322.1 |
|
Date of filing the European patent application |
2019-06-19 |
| (97) |
Date of publication of the European application |
2021-04-28 |
| (45) |
Date of publication and mention of the grant of the patent |
2023-09-13
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/EP2019/066295 |
|
Date |
2019-06-19 |
PCT application publication
| (87) |
Number |
WO 2019/243471 |
|
Date |
2019-12-26 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
201810058 |
2018-06-19
|
GB |
Inventors
| (72) |
PRESTEGARDEN, Lars , NO
|
Grantee
| (73) |
Cytovation ASA ,
Solheimsgaten 11, 5058 Bergen,
NO
|
Title
| (54) |
A COMBINATION COMPRISING USING AN OLIGOPEPTIDIC COMPOUND AND ANTI-PD-1 OR PD-L1 ANTIBODY FOR USE IN TREATING NEOPLASTIC CONDITIONS |
| |
A COMBINATION COMPRISING USING AN OLIGOPEPTIDIC COMPOUND AND ANTI-PD-1 OR PD-L1 ANTIBODY FOR USE IN TREATING NEOPLASTIC CONDITIONS |
